Ken Griffin Frequency Therapeutics, Inc. Transaction History

Citadel Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.35 - $0.72 $377,734 - $777,053	1,079,241 Added 86895.41%	1,080,483 $399,000
Q1 2023 May 15, 2023	SELL	$0.44 - $5.47 $17,421 - $216,579	-39,594 Reduced 96.96%	1,242 $0
Q4 2022 Feb 14, 2023	SELL	$1.88 - $3.85 $6,247 - $12,793	-3,323 Reduced 7.53%	40,836 $157,000
Q3 2022 Nov 14, 2022	SELL	$1.46 - $2.55 $114,579 - $200,121	-78,479 Reduced 63.99%	44,159 $79,000
Q2 2022 Aug 15, 2022	BUY	$1.03 - $2.03 $105,045 - $207,031	101,986 Added 493.83%	122,638 $183,000
Q4 2021 Feb 14, 2022	SELL	$4.95 - $7.11 $245,401 - $352,485	-49,576 Reduced 70.59%	20,652 $105,000
Q3 2021 Nov 15, 2021	SELL	$6.96 - $9.25 $261,180 - $347,115	-37,526 Reduced 34.83%	70,228 $496,000
Q2 2021 Aug 16, 2021	SELL	$8.05 - $11.61 $118,769 - $171,293	-14,754 Reduced 12.04%	107,754 $1.07 Million
Q1 2021 May 17, 2021	BUY	$7.99 - $55.01 $926,871 - $6.38 Million	116,004 Added 1783.58%	122,508 $1.16 Million
Q4 2020 Feb 16, 2021	BUY	$18.65 - $40.0 $121,299 - $260,160	6,504 New	6,504 $229,000
Q1 2020 May 15, 2020	SELL	$16.36 - $27.55 $181,759 - $306,080	-11,110 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.67 - $18.73 $140,763 - $208,090	11,110 New	11,110 $195,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.